Correlation Between Edesa Biotech and Pfizer

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Edesa Biotech and Pfizer at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Edesa Biotech and Pfizer into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Edesa Biotech and Pfizer Inc, you can compare the effects of market volatilities on Edesa Biotech and Pfizer and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Edesa Biotech with a short position of Pfizer. Check out your portfolio center. Please also check ongoing floating volatility patterns of Edesa Biotech and Pfizer.

Diversification Opportunities for Edesa Biotech and Pfizer

0.87
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Edesa and Pfizer is 0.87. Overlapping area represents the amount of risk that can be diversified away by holding Edesa Biotech and Pfizer Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pfizer Inc and Edesa Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Edesa Biotech are associated (or correlated) with Pfizer. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pfizer Inc has no effect on the direction of Edesa Biotech i.e., Edesa Biotech and Pfizer go up and down completely randomly.

Pair Corralation between Edesa Biotech and Pfizer

Given the investment horizon of 90 days Edesa Biotech is expected to under-perform the Pfizer. In addition to that, Edesa Biotech is 3.32 times more volatile than Pfizer Inc. It trades about -0.36 of its total potential returns per unit of risk. Pfizer Inc is currently generating about -0.24 per unit of volatility. If you would invest  2,801  in Pfizer Inc on August 26, 2024 and sell it today you would lose (236.00) from holding Pfizer Inc or give up 8.43% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

Edesa Biotech  vs.  Pfizer Inc

 Performance 
       Timeline  
Edesa Biotech 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Edesa Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
Pfizer Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pfizer Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's technical and fundamental indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.

Edesa Biotech and Pfizer Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Edesa Biotech and Pfizer

The main advantage of trading using opposite Edesa Biotech and Pfizer positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Edesa Biotech position performs unexpectedly, Pfizer can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pfizer will offset losses from the drop in Pfizer's long position.
The idea behind Edesa Biotech and Pfizer Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.

Other Complementary Tools

Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account